COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in… Dec 13, 2021
First-ever Human Data on SSRI – Psilocybin Interactive Effects Published by MindMed and Liechti Lab Nov 30, 2021
MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin Nov 30, 2021
MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs Jun 10, 2021